Literature DB >> 20686785

Ultrastructural evidence for human mast cell-eosinophil interactions in vitro.

Yael Minai-Fleminger1, Moran Elishmereni, Francesca Vita, Maria Rosa Soranzo, David Mankuta, Guliano Zabucchi, Francesca Levi-Schaffer.   

Abstract

We have hypothesized that mast cells (MC) and eosinophils (Eos), the main effectors of allergy, can form an effector unit. These cells co-exist in the inflamed tissues during the late and chronic stages of allergy and have been shown to be capable of influencing each other's survival and activity via soluble mediators. We have recently described couples of receptor-ligands that are expressed on either/both of these cells and that imply a physical interaction. In this study, we have investigated the existence of short-term (60 min) in vitro interactions between human peripheral blood Eos and cord-blood-derived MC by transmission electron microscopy. We have found that MC and Eos adhere to each other; the lipid body content and the granule morphology of co-cultured MC and Eos, respectively, are altered, and the level of Eos peroxidase (EPO) released by co-cultured Eos is elevated. Moreover, the transfer of EPO from Eos to MC and tryptase from MC to Eos has been observed. Our results thus indicate that, when co-cultured, MC and Eos show signs of physical contact and of reciprocal activation. This is the first in vitro evidence of functional physical interactions between human MC and Eos, interactions that might also occur in vivo during allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686785     DOI: 10.1007/s00441-010-1010-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  14 in total

1.  NOD1 and NOD2 Interact with the Phagosome Cargo in Mast Cells: A Detailed Morphological Evidence.

Authors:  Giuliano Zabucchi; Elisa Trevisan; Francesca Vita; Maria Rosa Soranzo; Violetta Borelli
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 2.  The Regulatory Function of Eosinophils.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  Microbiol Spectr       Date:  2016-10

3.  Characterization of mast cell secretory granules and their cell biology.

Authors:  Nurit Pereg Azouz; Ilan Hammel; Ronit Sagi-Eisenberg
Journal:  DNA Cell Biol       Date:  2014-07-02       Impact factor: 3.311

Review 4.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  Lipid body formation during maturation of human mast cells.

Authors:  Andrea Dichlberger; Stefanie Schlager; Jani Lappalainen; Reijo Käkelä; Katarina Hattula; Sarah J Butcher; Wolfgang J Schneider; Petri T Kovanen
Journal:  J Lipid Res       Date:  2011-10-04       Impact factor: 5.922

6.  Mast cell: an emerging partner in immune interaction.

Authors:  Giorgia Gri; Barbara Frossi; Federica D'Inca; Luca Danelli; Elena Betto; Francesca Mion; Riccardo Sibilano; Carlo Pucillo
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

7.  A novel mast cell-dependent allergic peritonitis model.

Authors:  Hadas Pahima; Pier Giorgio Puzzovio; Francesca Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  2021-06-20       Impact factor: 5.732

Review 8.  Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.

Authors:  Matthias Ceulemans; Inge Jacobs; Lucas Wauters; Tim Vanuytsel
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

Review 9.  Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Mansour Seaf; Giancarlo Marone; Francesca Levi-Schaffer; Gianni Marone
Journal:  Front Med (Lausanne)       Date:  2017-07-24

Review 10.  Mast cells: from lipid droplets to lipid mediators.

Authors:  Andrea Dichlberger; Petri T Kovanen; Wolfgang J Schneider
Journal:  Clin Sci (Lond)       Date:  2013-08       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.